Dolby Laboratories (NYSE:DLB) reported Q2 EPS of $0.92, $0.10 better than the analyst estimate of $0.82. Revenue for the quarter came in at $334.4 million versus the consensus estimate of $332.51 million.
Dolby Laboratories (NYSE:DLB) reported Q2 EPS of $0.92, $0.10 better than the analyst estimate of $0.82. Revenue for the quarter came in at $334.4 million versus the consensus estimate of $332.51 million.